Project Location. Except as otherwise permitted in Subsection 6.3 below, the Recipient agrees to carry out the Project exclusively in Canada located in Toronto, Ontario.
Appears in 2 contracts
Sources: Sif Agreement (Xanadu Quantum Technologies Inc.), Sif Agreement (Xanadu Quantum Technologies Inc.)
Project Location. Except as otherwise permitted in Subsection 6.3 6.5 below, the Recipient agrees to carry out the Project exclusively in Canada located in TorontoVancouver, OntarioBritish Columbia.
Appears in 2 contracts
Sources: Strategic Innovation Fund Agreement (AbCellera Biologics Inc.), Strategic Innovation Fund Agreement (AbCellera Biologics Inc.)
Project Location. Except as otherwise permitted in Subsection 6.3 6.4 below, the Recipient agrees to carry out the Project exclusively in Canada located in TorontoOttawa, OntarioOntario and in other locations across Canada.
Appears in 2 contracts
Sources: Strategic Innovation Fund Agreement, Strategic Innovation Fund Agreement (VBI Vaccines Inc/Bc)
Project Location. Except as otherwise permitted in Subsection 6.3 6.4 below, the Recipient agrees to carry out the Project exclusively in Canada located in TorontoToronto and the Greater Toronto Area, Ontario, and Montreal, Québec.
Appears in 1 contract
Sources: Strategic Innovation Fund Agreement (Edesa Biotech, Inc.)
Project Location. Except as otherwise permitted in Subsection 6.3 6.2 below, the Recipient agrees to carry out the Project exclusively in Canada located primarily in TorontoVancouver, OntarioBC and Montreal, QC, Canada.
Appears in 1 contract
Sources: Strategic Innovation Fund Agreement (AbCellera Biologics Inc.)
Project Location. Except as otherwise permitted in Subsection 6.3 6.4 below, the Recipient agrees to carry out the Project exclusively in Canada located in TorontoToronto and the ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇, Ontario▇▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇.
Appears in 1 contract
Sources: Strategic Innovation Fund Agreement (Edesa Biotech, Inc.)